[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646113":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":22,"responsibleParty":48,"collaborators":7,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":66,"studyType":67,"phases":7,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Firat University","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"MEHMET BALIN","PRINCIPAL_INVESTIGATOR",[13,19],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"MEHMET BALIN, MD,PROFFESOR","CONTACT","+905059174185","+905301178284","mehmetbalina@yahoo.com",{"name":20,"role":15,"phone":17,"phoneExt":17,"email":21},"ERKAN ÇEÇEN, MD","drerkancecen@gmail.com",[23,40],{"facility":5,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":7,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Elâzığ","Elaziğ","23000","Turkey (Türkiye)",{"type":30,"coordinates":31},"Point",[32,33],39.22321,38.67431,{"lat":33,"lon":32},[36],{"name":37,"role":15,"phone":38,"phoneExt":38,"email":39},"MEHMET ALI KOBAT, MD,PROFESSOR","+905322962880","mkobat@firat.edu.tr",{"facility":5,"status":24,"city":25,"state":41,"zip":27,"country":28,"countryCode":7,"cosmosGeoPoint":42,"geoPoint":44,"contacts":45},"Merkez",{"type":30,"coordinates":43},[32,33],{"lat":33,"lon":32},[46,47],{"name":37,"role":15,"phone":38,"phoneExt":7,"email":39},{"name":20,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":11,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Mehmet BALİN","MD, Professor","100646113","noninvasive-artificial-venous-stasis-for-reperfusion-in-stemi-100646113",false,"NCT07689591","Noninvasive Artificial Venous Stasis for Reperfusion in STEMI","Noninvasive Artificial Venous Stasis and Coronary Reperfusion in ST-Segment Elevation Myocardial Infarction:The RE-START STEMI Randomized Trial","RE-START","Inclusion Criteria:\n\n* Having presented within the first 12 hours of symptom onset Being hemodynamically stable (Killip Class I-II)\n\n  * STEMI diagnosis confirmed by coronary angiography\n  * Primary PCI (percutaneous coronary intervention) scheduled\n  * No pathology in the upper extremity that would prevent cuff application\n  * Be capable of providing informed consent and provide consent\n\nExclusion Criteria:\n\n* Presence of cardiogenic shock (systolic blood pressure \\\u003C 90 mmHg and Killip Class III-IV)\n\n  * Cardiac arrest occurring before or after the procedure\n  * Need for resuscitation following failed thrombolysis\n  * History of prior coronary artery bypass surgery\n  * Concurrent acute aortic dissection\n  * Venous thromboembolism or pulmonary embolism\n  * History of an acute infection within the past 7 days\n  * Chronic kidney disease requiring erythropoietin therapy or currently undergoing hemodialysis\n  * Presence of liver failure or a hematologic disorder\n  * Presence of any chronic inflammatory or autoimmune disease\n  * History of any known malignancy (cancer)\n  * Current treatment with glibenclamide, corticosteroids, antioxidant vitamins, or cyclosporine at the time of enrollment\n  * History of chronic (daily) alcohol consumption\n  * Contraindications to aspirin and\u002For clopidogrel\n  * Failure to confirm a STEMI diagnosis via coronary angiography\n  * Inability to provide informed consent\n  * Pregnancy\n  * First 6 months postpartum Conditions in which the administration of thrombolytics is contraindicated",true,"ALL","18 Years","80 Years",{"count":64,"type":65},500,"ESTIMATED","6 Months","OBSERVATIONAL","This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis \u002F RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.",[70],"STEMI - ST Elevation Myocardial Infarction",[72,73,74,75,76,77,78,79,80],"STEMI","Spontaneous Reperfusion","Primary Percutaneous Coronary Intervention","Infarct-Related Artery","TIMI Flow","Venous Stasis","Noninvasive Artificial Venous Stasis","RE-START Procedure","Coronary Reperfusion","2026-08-15",{"date":83,"type":84},"2026-08-18","ACTUAL",{"date":81,"type":84},{"date":87,"type":65},"2027-01-01",{"name":5,"class":6},2]